Home Careers Contact

Price: 3.15

Change: + 0.05

Day High: 3.20
Day Low: 3.05
Volume: 570,726

4:00 PM ET | Sep 22, 2017
Delayed 20 min., by eSignal.

Shareholder Tools

Committee Composition

  Audit Nominating and Governance Compensation
Garheng Kong, M.D., Ph.D Chairman of the Board Member of Audit Committee   Committee Chair for Compensation Committee
David Zaccardelli, Pharm.D.      
Richard Kent, M.D.     Member of Compensation Committee
David Gill Committee Chair for Audit Committee    

David Gill joined INC Research, a clinical research organization, in February 2011 as Chief Financial Officer after having served as a board member and Audit Committee chairman from 2007 to 2010. He was previously the Chief Financial Officer of TransEnterix, a private medical device company from March 2009 to February 2011. Mr. Gill was Chief Financial Officer and Treasurer of NxStage Medical, Inc, a publicly-traded dialysis equipment company, from July 2005 to November 2006 at which time he retired to pursue several board of director opportunities, including LeMaitre Vascular (LMAT) and Isotis Biologics (ISOT).

Mr. Gill served as Senior Vice President and Chief Financial Officer of CTI Molecular Imaging, Inc., a publicly-traded medical imaging company, from January 2002 to May 2005, before its sale. He served from February 2000 to March 2001 as Chief Financial Officer and Director, and from January 2001 to August 2001 as President, Chief Operating Officer, and Director, of Interland, Inc., a publicly-traded telecom-related company, before its sale. Previously, Mr. Gill served as the Chief Operating Officer and Chief Financial Officer of Novoste Corporation, a publicly-traded medical device company and as President of Dornier Medical Systems, a urologic equipment company.

Mr. Gill has led the IPO's of three companies and has raised more than $500 million in equity and $600 million in debt over his career. Mr. Gill holds a B.S. degree, cum laude, in Accounting from Wake Forest University and an M.B.A. degree, with honors, from Emory University, and was formerly a certified public accountant.

Dov A. Goldstein, M.D., M.B.A.   Committee Chair for Nominating and Governance Committee  
John H. Johnson   Member of Nominating and Governance Committee  
P. Sherrill Neff     Member of Compensation Committee
Michael Dougherty Member of Audit Committee Member of Nominating and Governance Committee  
Chair of the Board = Chair of the Board Committee Chair = Chair of the Committee Committee Member = Member

Stock transaction information provided by EDGAR Online. Cempra, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.